FDA
approval
· 2022-12-05
FDA Approved: LATANOPROST — Supplemental Application (Somerset Therapeutics, LLC)
Summary
The FDA approved a supplemental application for latanoprost from Somerset Therapeutics, LLC. Latanoprost is used to lower intraocular pressure in open-angle gla…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for LATANOPROST (LATANOPROST)